Non-Vitamin K Antagonist Oral Anticoagulants : A Concise Guide / by Eduard Shantsila, GREGORY LIP.

Format:

Book

Author/Creator:

Shantsila, Eduard, Author.

Lip, Gregory Y. H., Author.

Language:

English

Subjects (All):

Hematology.

Surgery.

Cardiology.

Local Subjects:

Hematology.

Surgery.

Cardiology.

Physical Description:

1 online resource (x, 97 pages) : illustrations; digital file(s).

Edition:

1st ed. 2016.

Place of Publication:

2015.

Cham : Springer International Publishing : Imprint: Adis, 2016.

Language Note:

English

System Details:

text file

Summary:

This book is an essential guide to the medical treatment of thrombosis and presents core principles of anticoagulant therapeutics as well as drug recommendations. Written by recognized experts in the field, this concise, accessible handbook provides a unique and valuable resource in the cardiovascular field, both for those currently in training, and for those already in clinical or research practice. .

Contents:

Intro

Contents

Chapter 1: Introduction

1.1 Overview of the Coagulation Cascade

1.2 Current Approaches to Anticoagulation

1.3 The Ideal Anticoagulant

References

Chapter 2: Direct Thrombin Inhibitors

2.1 Historical Excursus: Ximelagatran

2.2 Dabigatran Etexilate

2.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery

2.2.2 Venous Thromboembolism Treatment

2.2.3 Stroke Prevention in Atrial Fibrillation

2.2.4 Other Directions

Chapter 3: Factor Xa Inhibitors

3.1 Rivaroxaban

3.1.1 Venous Thromboembolism Prevention following Joint Surgery

3.1.2 Treatment of Venous Thromboembolism

3.1.3 Stroke Prevention in Atrial Fibrillation

3.1.4 Acute Coronary Syndromes

3.2 Apixaban

3.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery

3.2.2 Stroke Prevention in Atrial Fibrillation

3.2.3 Thromboprophylaxis in Other Clinical Settings

3.2.4 Treatment of Venous Thrombosis

3.2.5 Acute Coronary Syndrome

3.3 Edoxaban

3.3.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery

3.3.2 Stroke Prevention in Atrial Fibrillation

3.3.3 Treatment of Venous Thromboembolism

3.4 Emerging Factor Xa Inhibitors

3.4.1 Betrixaban

3.4.2 TTP889

Chapter 4: Conclusions

4.1 Future Directions

References.

Notes:

Bibliographic Level Mode of Issuance: Monograph

Description based on publisher supplied metadata and other sources.

ISBN:

3-319-25460-X

OCLC:

1066198411